Patent intelligence · US
US 9999634
Dissolution stability of calcium carbonate tablets
Dissolution stability of calcium carbonate tablets
Patent details — US 9999634
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 19, 2018
- Expiration
- Jun 14, 2038
- Applicant
- TAKEDA AS
- Claims
- 14
- CPC classes
- A61K, A61K33/06, A61K33/10, A61K9/2018
Quick answer
US 9999634 (Dissolution stability of calcium carbonate tablets) is held by TAKEDA AS. Status: granted. Granted Jun 19, 2018. Expires Jun 14, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- TAKEDA AS
- Grant date
- Expiration
- Claims
- 14
- CPC classes
- A61K, A61K33/06, A61K33/10, A61K9/2018, A61K9/2072, A61K9/2095
More from TAKEDA AS
Related pharmaceutical patents in our USPTO index.
-
US 12428403
N-(heterocyclyl and heterocyclylalkyl)-3-benzylpyridin-2-amine derivatives as SSTR4 agonists
granted -
US 12421188
Heterocyclic compound and use thereof
granted -
US 12419890
Administration of sumo-activating enzyme inhibitor and checkpoint inhibitors
granted -
US 12415866
Monoclonal antibody inhibitor of Factor XIIa
granted -
US 12415782
Heterocyclic compound and use thereof
granted -
US 12409210
CNS delivery of therapeutic agents
granted -
US 12404237
Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives
granted -
US 12403154
Administration of sting agonist and checkpoint inhibitors
granted
Frequently asked questions
What is US patent 9999634?
US 9999634 (Dissolution stability of calcium carbonate tablets) is held by TAKEDA AS. Status: granted. Granted Jun 19, 2018. Expires Jun 14, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9999634?
TAKEDA AS is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 1,436 pharmaceutical patents for this assignee.
When does US 9999634 expire?
Our index shows an expiration date of Jun 14, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.